Published On:March 27 2014
Story Viewed 1538 Times
Caplin Point Laboratories spurts after commencement of commercial production at a plant.
Caplin Point Laboratories was locked at 5% upper circuit at Rs. 175.50 on BSE after the company said that its state-of-art injectable plant near Gummidipoondi, Tamil Nadu has commenced its commercial production on, 27 March 2014.
BS